Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.
about
Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.Genomic profiling of collecting duct renal carcinomaCharacterizing genomic differences of human cancer stratified by the TP53 mutation status.Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice
P2860
Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Collecting duct carcinoma of t ...... SLC family gene up-regulation.
@en
Collecting duct carcinoma of t ...... SLC family gene up-regulation.
@nl
type
label
Collecting duct carcinoma of t ...... SLC family gene up-regulation.
@en
Collecting duct carcinoma of t ...... SLC family gene up-regulation.
@nl
prefLabel
Collecting duct carcinoma of t ...... SLC family gene up-regulation.
@en
Collecting duct carcinoma of t ...... SLC family gene up-regulation.
@nl
P2093
P2860
P50
P356
P1433
P1476
Collecting duct carcinoma of t ...... SLC family gene up-regulation
@en
P2093
Antonios Papanicolau-Sengos
Carl Morrison
Cristina Magi-Galluzzi
Jeffrey M Conroy
Jianmin Wang
Kiersten Marie Miles
Manuela Costantini
P2860
P304
29901-29915
P356
10.18632/ONCOTARGET.9093
P407
P577
2016-05-01T00:00:00Z